GB1338740A - 3-formylrifamycin sv derivatives - Google Patents

3-formylrifamycin sv derivatives

Info

Publication number
GB1338740A
GB1338740A GB1945772A GB1945772A GB1338740A GB 1338740 A GB1338740 A GB 1338740A GB 1945772 A GB1945772 A GB 1945772A GB 1945772 A GB1945772 A GB 1945772A GB 1338740 A GB1338740 A GB 1338740A
Authority
GB
United Kingdom
Prior art keywords
formylrifamycin
alkyl
oximes
mono
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1945772A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8960771A external-priority patent/IT1045053B/en
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of GB1338740A publication Critical patent/GB1338740A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1338740 3-formylrifamycin SV oximes GRUPPO LEPETIT SpA 2 May 1972 [7 June 1971 24 June 1971] 19457/72 Heading C2A The invention comprises 3-formylrifamycin SV oximes of general Formula I wherein R is alkyl of at least two carbon atoms, alkenyl, alkynyl, cycloalkyl, alkoxyalkyl, cycloalkoxyalkyl, hydroxyalkyl, carboxyalkyl, carbalkoxyalkyl, carbamyl alkyl, cyanoalkyl, nitroalkyl, aryloxyalkyl, aralkoxyalkyl, heterocycloxyalkyl, aminoalkyl, mono and di-alkylaminoalkyl, substituted benzyl, mono- and poly-aryl substituted C 2 -C 8 alkyl or alkyl substituted with 1 to 3 mono or polynuclear heterocyclic rings containing at least one heteroatom selected from O, N and S, with the exclusion of morpholine and R 1 is hydrogen or acetyl and the derivatives of the same oximes hydrogenated in the positions 16, 17, 18, 19, 28, 29. A process for preparing an oxime of Formula I comprises reacting a compound selected from 3-formylrifamycin SV, 25-desacetyl-3-formylrifamycin SV and their derivatives hydrogenated in the positions 16, 17, 18, 19, 28, 29 with about an equimolar amount of an O-substitutedhydroxylamine of the general formula RONH 2 . Therapeutic compositions comprise as the active ingredient a compound of Formula I together with a pharmaceutically acceptable carrier.
GB1945772A 1971-06-07 1972-05-02 3-formylrifamycin sv derivatives Expired GB1338740A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2549371 1971-06-07
IT8960771A IT1045053B (en) 1971-06-24 1971-06-24 Oximes of 3-formylrifamycin - as antibiotics and dna polymerase inhibitors

Publications (1)

Publication Number Publication Date
GB1338740A true GB1338740A (en) 1973-11-28

Family

ID=26328602

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1945772A Expired GB1338740A (en) 1971-06-07 1972-05-02 3-formylrifamycin sv derivatives

Country Status (20)

Country Link
JP (1) JPS517679B1 (en)
AR (1) AR192938A1 (en)
BE (1) BE784533A (en)
CA (1) CA966481A (en)
CH (1) CH562248A5 (en)
DD (1) DD99782A5 (en)
DE (1) DE2227087C2 (en)
DK (1) DK137992B (en)
ES (1) ES403548A1 (en)
FI (1) FI58923C (en)
FR (1) FR2140534B1 (en)
GB (1) GB1338740A (en)
HU (1) HU163900B (en)
IE (1) IE37664B1 (en)
IL (1) IL39305A (en)
LU (1) LU65461A1 (en)
NL (1) NL153202B (en)
NO (1) NO135316C (en)
RO (1) RO62437A (en)
SU (1) SU432721A3 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (en) * 1964-07-31

Also Published As

Publication number Publication date
FR2140534A1 (en) 1973-01-19
FI58923C (en) 1981-05-11
NL7207698A (en) 1972-12-11
DD99782A5 (en) 1973-08-20
DE2227087A1 (en) 1973-04-12
IL39305A0 (en) 1972-06-28
NO135316C (en) 1977-03-23
JPS517679B1 (en) 1976-03-10
LU65461A1 (en) 1972-10-23
DK137992C (en) 1978-11-13
FI58923B (en) 1981-01-30
NL153202B (en) 1977-05-16
DE2227087C2 (en) 1982-09-02
IE37664B1 (en) 1977-09-14
RO62437A (en) 1978-01-15
ES403548A1 (en) 1975-05-01
DK137992B (en) 1978-06-19
AR192938A1 (en) 1973-03-21
CH562248A5 (en) 1975-05-30
IL39305A (en) 1975-08-31
FR2140534B1 (en) 1975-10-31
HU163900B (en) 1973-11-28
NO135316B (en) 1976-12-13
BE784533A (en) 1972-10-02
SU432721A3 (en) 1974-06-15
IE37664L (en) 1972-12-07
CA966481A (en) 1975-04-22

Similar Documents

Publication Publication Date Title
ES474592A1 (en) Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds.
IE861723L (en) Heterocyclic substituted isoxazoles
RU94039540A (en) Method of uterus fibrosis inhibition
ES8504805A1 (en) Tri- and tetracyclic imidazo(1,5-a)(1,4)benzodiazepin-1-carboxylic-acid derivatives.
GB1338740A (en) 3-formylrifamycin sv derivatives
GB1468114A (en) Triazino 4,3-a 1,4-benzodiazepin-2 1h-ones and their pharmaceuti cal compositions
ES8502997A1 (en) Substituted imidazo(1,5-a)pyridines, process for their preparation and pharmaceutical preparations containing these compounds.
ES8604960A1 (en) 1,6-Naphthyridine derivatives, process for their preparation and medicament containing them.
KR900016210A (en) New compounds
ES473900A1 (en) Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them.
GB1336399A (en) 3-formylrifamycin sv derivatives
ES8101074A1 (en) Theophylline derivatives, process for their preparation and medicaments containing these compounds.
ES479440A1 (en) Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use.
ES8302732A1 (en) Imidazo-rifamycines, process for their preparation, pharmaceutical preparations containing them and their use.
GB1424147A (en) Agents for regulating plant growth
ES430676A1 (en) 2-Substituted -1,2,4-thiadiazolo-(2,3-a)benzimidazoles and process for their preparation
GB2006196A (en) Phenylacetamides with analgesic activity
ES2018404A6 (en) 2-methoxycarbonyl substituted N,N'-di-(trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them
ES481211A1 (en) Aminoalkylthiodibenzoxepines, their preparation and pharmaceutical compositions containing them.
ES8407035A1 (en) Dextrogyrating isomers of 1-aza-bicyclo(2,2,2)octane derivatives, their preparation and pharmaceutical preparations containing them.
WO1998049165B1 (en) CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO[2,3,4-kl] ACRIDINE RING SYSTEM
ES476232A1 (en) Phosphonyl-ureido-benzene derivatives, process for their preparation and their application in drugs.
ES469426A1 (en) Thienamycin derivatives
GB1389100A (en) 3-alkenyl derivatives of rifamycin sv
GB1283187A (en) Improvements in or relating to rifamycin derivatives and the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee